Steward Health Care claims former executives’ “greed and bad faith misconduct” led to hospitals chain’s bankruptcy

Steward Health Care, a once-thriving hospital chain that has been under intense federal scrutiny, is now embroiled in legal battles as it files court documents accusing its former CEO and three other executives of financial mismanagement. The company alleges that Ralph de la Torre, along with Michael Callum, James Karam, and Sanjay Shetty, misappropriated over $245 million, leading the chain into bankruptcy.

The allegations against the former insiders claim that they operated Steward with the sole purpose of enriching themselves at the expense of the company, its creditors, and the patients and communities it served. The court filing states that these individuals pilfered Steward’s assets for personal gain, leaving the company perpetually undercapitalized and insolvent.

Steward Health Care, once the nation’s largest for-profit hospital chain, operated hospitals across several states, including Massachusetts, Texas, Florida, and Pennsylvania. An investigation by CBS News revealed how de la Torre and private equity investors extracted hundreds of millions of dollars in dividends from real estate sales, while hospitals faced shortages of life-saving supplies.

Records reviewed by CBS News showed instances where Steward hospitals left unpaid bills, jeopardizing patient care. Tragically, a young mother died after giving birth when a device that could have saved her life was repossessed due to unpaid bills. Following bankruptcy filings, the company sold off several hospitals, leaving thousands of workers unemployed.

In response to the allegations, a spokesperson for Steward reiterated the company’s commitment to patient care and denied placing any other considerations above the well-being of patients. De la Torre defended the company’s actions, stating that Steward had made significant investments in its hospital system since its inception.

The court complaint outlines three major transactions where de la Torre and executives allegedly profited at the expense of Steward’s financial stability. In one instance, de la Torre reportedly received a $111 million dividend payout while the company was struggling financially. The complaint also details how executives benefited from various deals, including overpayments for hospital acquisitions and asset sales.

As the legal battle unfolds, Steward Health Care faces intense scrutiny over its financial practices and the impact on patient care. The outcome of the case will shed light on the alleged misconduct by former executives and its repercussions on the healthcare system. A recent complaint has been filed against former CareMax CEO Ralph de la Torre and other board members, accusing them of selling off valuable assets and pocketing the proceeds as the company faced insolvency. The complaint alleges that de la Torre, along with Callum and Karam, were negligent in their duties and breached their obligations of care, loyalty, and good faith.

CareMax, which filed for bankruptcy in February, is now under the administration of a court-appointed administrator who is working to recover funds from the former leaders to repay creditors. De la Torre, who founded the company in 2010, is under scrutiny in a federal probe investigating potential fraud, embezzlement, and violations of the Foreign Corrupt Practices Act. He has also faced consequences for refusing to appear before the Senate Health, Education, Labor, and Pensions Committee and was held in contempt for his failure to comply with a subpoena.

Amidst the company’s financial struggles, reports have surfaced detailing de la Torre’s extravagant personal spending, including the purchase of a $30 million yacht, a multimillion-dollar Texas horse ranch, and two corporate jets valued at $95 million. Despite the allegations, a spokesperson for de la Torre has stated that he disputes the accusations of wrongdoing and plans to vigorously defend himself.

As the investigation unfolds and legal proceedings continue, the spotlight remains on the actions of de la Torre and the other former leaders of CareMax. The repercussions of their alleged misconduct have not only impacted the company’s financial stability but have also raised questions about corporate governance and accountability in the healthcare industry. It remains to be seen how the case will unfold and what consequences will be faced by those involved in the alleged mismanagement of CareMax.